TWST Twist Bioscience Corp
Price (delayed)
$52.02
Market cap
$3.1B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.38
Enterprise value
$2.98B
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of
Highlights
TWST's gross profit has surged by 57% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 26% YoY and by 6% from the previous quarter
Twist Bioscience's equity has decreased by 23% YoY and by 3.5% QoQ
TWST's quick ratio is down by 16% year-on-year
Key stats
What are the main financial stats of TWST
Market
Valuations
Earnings
Shares outstanding
59.65M
Market cap
$3.1B
Enterprise value
$2.98B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.77
Price to sales (P/S)
9.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.02
Revenue
$330.19M
Gross profit
$147.23M
Operating income
-$208.5M
Net income
-$197.31M
EBIT
-$196.72M
EBITDA
-$166.39M
Free cash flow
-$68.39M
Per share
Balance sheet
Liquidity
EPS
-$3.38
EPS diluted
-$3.38
Free cash flow per share
-$1.16
Book value per share
$7.68
Revenue per share
$5.58
TBVPS
$8.6
Total assets
$608.58M
Total liabilities
$152.64M
Debt
$97.62M
Equity
$455.94M
Working capital
$275.66M
Debt to equity
0.21
Current ratio
4.96
Quick ratio
4.45
Net debt/EBITDA
0.74
Margins
Efficiency
Dividend
EBITDA margin
-50.4%
Gross margin
44.6%
Net margin
-59.8%
Operating margin
-63.1%
Return on assets
-30.8%
Return on equity
-39.9%
Return on invested capital
-61.8%
Return on capital employed
-36.5%
Return on sales
-59.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TWST stock price
How has the Twist Bioscience stock price performed over time
Intraday
-1.38%
1 week
0.31%
1 month
9.91%
1 year
42.17%
YTD
11.94%
QTD
11.94%
Financial performance
How have Twist Bioscience's revenue and profit performed over time
Revenue
$330.19M
Gross profit
$147.23M
Operating income
-$208.5M
Net income
-$197.31M
Gross margin
44.6%
Net margin
-59.8%
TWST's gross profit has surged by 57% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 26% YoY and by 6% from the previous quarter
Twist Bioscience's operating margin has increased by 25% YoY and by 11% QoQ
TWST's gross margin is up by 25% year-on-year and by 4.7% since the previous quarter
Growth
What is Twist Bioscience's growth rate over time
Valuation
What is Twist Bioscience stock price valuation
P/E
N/A
P/B
6.77
P/S
9.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.02
TWST's EPS is up by 6% year-on-year and by 6% since the previous quarter
TWST's P/B is 30% above its 5-year quarterly average of 5.2 and 28% above its last 4 quarters average of 5.3
Twist Bioscience's equity has decreased by 23% YoY and by 3.5% QoQ
TWST's P/S is 54% below its 5-year quarterly average of 20.4 but 11% above its last 4 quarters average of 8.4
TWST's revenue is up by 26% YoY and by 6% from the previous quarter
Efficiency
How efficient is Twist Bioscience business performance
The return on equity has declined by 25% year-on-year
TWST's return on sales is up by 24% year-on-year and by 10% since the previous quarter
The ROA has decreased by 19% YoY
Twist Bioscience's ROIC has decreased by 15% YoY but it has increased by 2.7% from the previous quarter
Dividends
What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TWST.
Financial health
How did Twist Bioscience financials performed over time
The current ratio has contracted by 17% YoY
Twist Bioscience's total assets has decreased by 17% YoY
Twist Bioscience's debt is 79% less than its equity
Twist Bioscience's debt to equity has increased by 31% YoY and by 17% QoQ
Twist Bioscience's equity has decreased by 23% YoY and by 3.5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.